News & Analysis as of

Foreign Investment Investment Opportunities Pharmaceutical Industry

Latham & Watkins LLP

Saudi Arabia Issues Decree to Permit Foreign Ownership of Retail Pharmacies

Latham & Watkins LLP on

The new law, which offers a unique opportunity for investors in Saudi Arabia’s pharmacy market, forms part of a broader strategy to encourage innovation and foreign investment. The Kingdom of Saudi Arabia (KSA) has opened...more

McDermott Will & Schulte

[Event] SuperReturn International Conference Panel Discussion and Reception - February 26th, Germany

McDermott Will & Emery is delighted to welcome you to a panel discussion on “Private Equity in Healthcare” and a social reception held in conjunction with the SuperReturn International Conference 2020. Our speakers will...more

McDermott Will & Schulte

[Event] 3rd Annual Shanghai Life Sciences Forum - November 12th, Shanghai, China

McDermott Will & Schulte on

MWE China Law Offices and its strategic alliance partner McDermott Will & Emery are proud to co-host our annual Shanghai Life Sciences Forum in partnership with the Redefining Early Stage Investments (RESI) conference. This...more

Hogan Lovells

Regulatory Insights for Life Sciences and Health Care Investments: CFIUS reporting obligations

Hogan Lovells on

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product's success or failure could cost you millions of dollars....more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide